x
Japan Biobanking Market Overview
Market Statistics
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 3,803 Million
Market Forecast in 2033: USD 5,611 Million
Market Growth Rate: 4.4% (2025-2033)
According to the latest report by IMARC Group, the Japan biobanking market size reached USD 3,803 million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,611 million by 2033, exhibiting a CAGR of 4.4% from 2025 to 2033.
Download a Sample PDF of This Report: https://www.imarcgroup.com/japan-biobanking-market/requestsample
Japan Biobanking Industry Trends and Drivers
The biobanking industry in Japan is undergoing consistent development, significantly supported by events that are shaping the fields of personalized medicine, an expanding capacity to bio-sample high quality biological materials, and a focus on medical research. The aging population combined with the increased incidence of disease states, such as cancer and cardiovascular disease, is contributing significantly to the need for biobanks to help develop new drugs and to take up and utilize precision medicine. Given that disease-oriented biobanks focus their collections around specific diseases, they dominate the biobanking industry currently, while population-based biobanks are less common, but are beginning to emerge and grow alongside genomic studies that occupy a large footprint. As for the biological material collected, blood products and nucleic acids are the most common because they are often useful in determining biomarkers and use the fastest growing areas in research. The application segment for research occupies the largest market share and is supported by government-funded organizations and initiatives, such as networks for biobanks, through the Japan Agency for Medical Research and Development (AMED).
The key end-users are pharmaceutical and biotech companies who support drug discovery and development, while knowledge responsive virtue receptors, also name academic institutions, support innovation in translational research. The Kanto region (Tokyo) possesses the largest market share because there are a number of research institutes and biotech companies in Tokyo. Kinki and Chubu regions rank second and third in market share respectively. The key challenges for made in collections include strict ethical guidelines and regulations surrounding the collection, as well as significant costs required to operate biobanks. Many opportunities for the biobanks industry exist in the area of artificial intelligence support for data management, automating certain sample processing in collections, and collaborations, likely international, with reliable partners to share knowledge to develop effective processes in biobanking frameworks and connect to global biobanking standards.
Japan Biobanking Market Segmentation
The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan biobanking market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments:
Specimen Type Insights:
Biobank Type Insights:
Application Insights:
End User Insights:
Regional Insights:
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=18685&flag=C
Competitive Landscape
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of major companies in the Japan biobanking industry.
Other Key Points Covered in the Report:
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact:
Street: 563-13 Kamien
Area: Iwata
Country: Tokyo, Japan
Postal Code: 4380111
Email: sales@imarcgroup.com
